0000000000552241
AUTHOR
Diana Taylor
A Forum on Theatre and Tragedy: A Response to September 11, 2001
A Forum on Theatre and Tragedy in the Wake of September 11, 2001 Author(s): Diana Taylor, Una Chaudhuri, W. B. Worthen, Jennifer DeVere Brody, Harry J. Elam, Jr., Amy Villarejo, Jill Dolan, Sue-Ellen Case, Jill Lane, Antonio Prieto, Freddie Rokem, Ann Pellegrini, Christopher B. Balme, Alicia Arrizon, Sharon P. Holland, Brian Singleton, Michal Kobialka, Jose Esteban Munoz, Karen Shimakawa, Bob Vorlicky, Josh Kun, Roberta Uno, Alice Raynor, Richard Schechner, Marvin Carlson, Janelle Reinelt and Eli ... Source: Theatre Journal, Vol. 54, No. 1, Tragedy (Mar., 2002), pp. 95-138 Published by: The Johns Hopkins University Press Stable URL: http://www.jstor.org/stable/25069023 . Accessed: 25/04/201…
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
BACKGROUND Degludec is an ultralong-Acting, once-daily basal insulin that is approved for use in adults, adolescents, and children with diabetes. Previous open-label studies have shown lower day-To-day variability in the glucose-lowering effect and lower rates of hypoglycemia among patients who received degludec than among those who received basal insulin glargine. However, data are lacking on the cardiovascular safety of degludec. METHODS We randomly assigned 7637 patients with type 2 diabetes to receive either insulin degludec (3818 patients) or insulin glargine U100 (3819 patients) once daily between dinner and bedtime in a double-blind, treat-To-Target, event-driven cardiovascular outco…